Establishing a robust corporate structure and earnings base
First written in FY2016. 4 of 6 entries say "Restated". Latest entry: FY2026.
38 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「Going forward, with the clinical testing business as our main focus, our group will strive for sustainable growth and further enhancement of corporate value by continuing its “relentless pursuit of improvements in quality and productivity” in this field.」
The company continues to pursue sustainable growth and enhanced corporate value by continuing to improve quality and productivity, centered on the clinical testing business. - FY2025RestatedAnnual report
「Going forward, with the clinical testing business as our main focus, our group will strive for sustainable growth and further enhancement of corporate value by continuing its “relentless pursuit of improvements in quality and productivity” in this field.」
The company continues to pursue sustainable growth and enhanced corporate value through improvements in quality and productivity, centered on the clinical testing business. - FY2024ReframedAnnual report
「Going forward, with the clinical testing business as our main focus, our group will strive for sustainable growth and further enhancement of corporate value by continuing its “relentless pursuit of improvements in quality and productivity” in this field.」
The company has broadened the expression of its challenge from establishing a robust corporate structure and earnings base to achieving sustainable growth and enhancing corporate value through improvements in quality and productivity. - FY2019RestatedAnnual report
「Accordingly, establishing a robust corporate structure and earnings base capable of withstanding this environment has become an urgent priority.」
The company continues to identify establishing a corporate structure and earnings base capable of withstanding price competition and the impact of healthcare policy as a key challenge. - FY2017RestatedAnnual report
「Accordingly, establishing a robust corporate structure and earnings base capable of withstanding this environment has become an urgent priority.」
The company continues to identify establishing a corporate structure and earnings base capable of withstanding price competition and the impact of healthcare policy as a key challenge. - FY2016First statedAnnual report
「Accordingly, establishing a robust corporate structure and earnings base capable of withstanding this environment has become an urgent priority.」
The company has identified establishing a corporate structure and earnings base capable of withstanding price competition and the impact of healthcare policy as a key challenge.